Scout | PAR-24-221: NINDS SBIR Phase IIB Bridge Awards for Early Neurology Clinical Trials (R44)

This opportunity is no longer accepting applications.

grant PAR-24-221

NINDS SBIR Phase IIB Bridge Awards for Early Neurology Clinical Trials (R44)

Summary

NINDS offers SBIR Phase IIB Bridge Awards to small businesses to run early clinical trials and studies of neurological therapies, devices, diagnostics, or tools that advance toward commercialization. Projects must extend a prior NIH SBIR/STTR Phase II award, can include up to three clinical sites, and FDA-regulated studies must have FDA authorization in place. Applicants are expected to secure…

Purpose

NINDS is committed to advancing treatments, tools, and diagnostics that benefit people burdened by neurological diseases through the NINDS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The SBIR/STTR Programs are structured in thr…

Funding Source

Agency: National Institutes of Health

Sub-agency: National Institute of Neurological Disorders and Stroke

Phase: Phase II

Awards & funding

Award Ceiling: $2M

Eligibility

Joint ventures of eligible SBCs (each joint venture entity must meet SBA SBIR/STTR ownership requirements; joint venture must have <50% participation by foreign business entities; if includes VCOC-owned concerns, must comply with 13 C.F.R. §121.705(b) registration/proposal requirements)

Tribal-/ANC-/NHO-owned U.S. Small Business Concerns (including wholly owned business entities of an Indian tribe, Alaska Native Corporation, or Native Hawaiian Organization)

SBIR-only: SBCs >50% owned by multiple venture capital operating companies, hedge funds, private equity firms, or any combination (no single such firm may own >50% unless that firm itself qualifies as an SBC that is >50% owned and controlled by U.S. individuals)

Only United States small business concerns (SBCs) are eligible to submit applications to this NOFO. Key SBA SBIR/STTR eligibility criteria that must be met at the time of award (Phase I and II) include: • Organized for profit; U.S. place of business; operates primarily in the U.S. or makes a sig…

Dates

Opportunity Released: June 20, 2024

Open for Submission: June 20, 2024

Submission Deadline: April 5, 2027

Application Window Closes: April 5, 2027

Supporting links

National Institutes of Health

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers